| Seth L Krauss, MD | |
|
3841 Piper Street, Suite T100, Anchorage, AK 99508 | |
| (907) 561-3211 | |
| (907) 562-7547 |
| Full Name | Seth L Krauss |
|---|---|
| Gender | Male |
| Speciality | Peripheral Vascular Disease |
| Experience | 39 Years |
| Location | 3841 Piper Street, Anchorage, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801814173 | NPI | - | NPPES |
| 060051652 | Other | AK | RAILROAD MEDICARE |
| 1012450 | Medicaid | AK |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Alaska Medical Center | Anchorage, AK | Hospital |
| Alaska Regional Hospital | Anchorage, AK | Hospital |
| Central Peninsula General Hospital | Soldotna, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alaska Heart Institute | 2668371469 | 57 |
| Providence Health And Services Washington | 2163335746 | 27 |
| Providence Health And Services Washington | 5799675120 | 15 |
News Archive
AIDS Healthcare Foundation (AHF) today applauded decisions by Boehringer Ingelheim (BI) and Gilead Sciences, Inc. to freeze prices on antiretroviral medications purchased by government agencies.
The use of biologics, which are generally made from human and/or animal materials, has significantly changed the management of rheumatoid arthritis over the last decade, becoming the cornerstone treatment for many patients.
Bbiotechnology company NEUROKIN, dedicated to the development of neuroprotective drugs to treat acute neurological diseases, announces today that the European Patent Office (EPO) has granted patent EP 1998778 protecting the use of NK-102, its most advanced drug candidate. This first European award constitutes an important milestone for NEUROKIN. An application for registration is under way in Brazil, Canada, China, USA and Japan.
More than three-quarters of a million low-income adults in Los Angeles County live with hunger or make daily decisions about whether to eat or pay for other essential needs such as shelter or clothing, according to a new UCLA Center for Health Policy Research report.
Less than half of individuals with peripheral artery disease, which is a narrowing of arteries to the limbs, stomach and head, are treated with appropriate medications and lifestyle counseling. These findings highlight the need to improve the quality of care for this high-risk group of individuals.
› Verified 9 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467547265 PECOS PAC ID: 2163335746 Enrollment ID: O20031110000525 |
News Archive
AIDS Healthcare Foundation (AHF) today applauded decisions by Boehringer Ingelheim (BI) and Gilead Sciences, Inc. to freeze prices on antiretroviral medications purchased by government agencies.
The use of biologics, which are generally made from human and/or animal materials, has significantly changed the management of rheumatoid arthritis over the last decade, becoming the cornerstone treatment for many patients.
Bbiotechnology company NEUROKIN, dedicated to the development of neuroprotective drugs to treat acute neurological diseases, announces today that the European Patent Office (EPO) has granted patent EP 1998778 protecting the use of NK-102, its most advanced drug candidate. This first European award constitutes an important milestone for NEUROKIN. An application for registration is under way in Brazil, Canada, China, USA and Japan.
More than three-quarters of a million low-income adults in Los Angeles County live with hunger or make daily decisions about whether to eat or pay for other essential needs such as shelter or clothing, according to a new UCLA Center for Health Policy Research report.
Less than half of individuals with peripheral artery disease, which is a narrowing of arteries to the limbs, stomach and head, are treated with appropriate medications and lifestyle counseling. These findings highlight the need to improve the quality of care for this high-risk group of individuals.
› Verified 9 days ago
| Entity Name | Alaska Heart Institute |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992744114 PECOS PAC ID: 2668371469 Enrollment ID: O20031231000146 |
News Archive
AIDS Healthcare Foundation (AHF) today applauded decisions by Boehringer Ingelheim (BI) and Gilead Sciences, Inc. to freeze prices on antiretroviral medications purchased by government agencies.
The use of biologics, which are generally made from human and/or animal materials, has significantly changed the management of rheumatoid arthritis over the last decade, becoming the cornerstone treatment for many patients.
Bbiotechnology company NEUROKIN, dedicated to the development of neuroprotective drugs to treat acute neurological diseases, announces today that the European Patent Office (EPO) has granted patent EP 1998778 protecting the use of NK-102, its most advanced drug candidate. This first European award constitutes an important milestone for NEUROKIN. An application for registration is under way in Brazil, Canada, China, USA and Japan.
More than three-quarters of a million low-income adults in Los Angeles County live with hunger or make daily decisions about whether to eat or pay for other essential needs such as shelter or clothing, according to a new UCLA Center for Health Policy Research report.
Less than half of individuals with peripheral artery disease, which is a narrowing of arteries to the limbs, stomach and head, are treated with appropriate medications and lifestyle counseling. These findings highlight the need to improve the quality of care for this high-risk group of individuals.
› Verified 9 days ago
| Entity Name | Mat Su Valley Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912950148 PECOS PAC ID: 5698686475 Enrollment ID: O20040123000583 |
News Archive
AIDS Healthcare Foundation (AHF) today applauded decisions by Boehringer Ingelheim (BI) and Gilead Sciences, Inc. to freeze prices on antiretroviral medications purchased by government agencies.
The use of biologics, which are generally made from human and/or animal materials, has significantly changed the management of rheumatoid arthritis over the last decade, becoming the cornerstone treatment for many patients.
Bbiotechnology company NEUROKIN, dedicated to the development of neuroprotective drugs to treat acute neurological diseases, announces today that the European Patent Office (EPO) has granted patent EP 1998778 protecting the use of NK-102, its most advanced drug candidate. This first European award constitutes an important milestone for NEUROKIN. An application for registration is under way in Brazil, Canada, China, USA and Japan.
More than three-quarters of a million low-income adults in Los Angeles County live with hunger or make daily decisions about whether to eat or pay for other essential needs such as shelter or clothing, according to a new UCLA Center for Health Policy Research report.
Less than half of individuals with peripheral artery disease, which is a narrowing of arteries to the limbs, stomach and head, are treated with appropriate medications and lifestyle counseling. These findings highlight the need to improve the quality of care for this high-risk group of individuals.
› Verified 9 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952430902 PECOS PAC ID: 5799675120 Enrollment ID: O20040318000605 |
News Archive
AIDS Healthcare Foundation (AHF) today applauded decisions by Boehringer Ingelheim (BI) and Gilead Sciences, Inc. to freeze prices on antiretroviral medications purchased by government agencies.
The use of biologics, which are generally made from human and/or animal materials, has significantly changed the management of rheumatoid arthritis over the last decade, becoming the cornerstone treatment for many patients.
Bbiotechnology company NEUROKIN, dedicated to the development of neuroprotective drugs to treat acute neurological diseases, announces today that the European Patent Office (EPO) has granted patent EP 1998778 protecting the use of NK-102, its most advanced drug candidate. This first European award constitutes an important milestone for NEUROKIN. An application for registration is under way in Brazil, Canada, China, USA and Japan.
More than three-quarters of a million low-income adults in Los Angeles County live with hunger or make daily decisions about whether to eat or pay for other essential needs such as shelter or clothing, according to a new UCLA Center for Health Policy Research report.
Less than half of individuals with peripheral artery disease, which is a narrowing of arteries to the limbs, stomach and head, are treated with appropriate medications and lifestyle counseling. These findings highlight the need to improve the quality of care for this high-risk group of individuals.
› Verified 9 days ago
| Entity Name | South Peninsula Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679566269 PECOS PAC ID: 5395636930 Enrollment ID: O20040323000583 |
News Archive
AIDS Healthcare Foundation (AHF) today applauded decisions by Boehringer Ingelheim (BI) and Gilead Sciences, Inc. to freeze prices on antiretroviral medications purchased by government agencies.
The use of biologics, which are generally made from human and/or animal materials, has significantly changed the management of rheumatoid arthritis over the last decade, becoming the cornerstone treatment for many patients.
Bbiotechnology company NEUROKIN, dedicated to the development of neuroprotective drugs to treat acute neurological diseases, announces today that the European Patent Office (EPO) has granted patent EP 1998778 protecting the use of NK-102, its most advanced drug candidate. This first European award constitutes an important milestone for NEUROKIN. An application for registration is under way in Brazil, Canada, China, USA and Japan.
More than three-quarters of a million low-income adults in Los Angeles County live with hunger or make daily decisions about whether to eat or pay for other essential needs such as shelter or clothing, according to a new UCLA Center for Health Policy Research report.
Less than half of individuals with peripheral artery disease, which is a narrowing of arteries to the limbs, stomach and head, are treated with appropriate medications and lifestyle counseling. These findings highlight the need to improve the quality of care for this high-risk group of individuals.
› Verified 9 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1013905660 PECOS PAC ID: 5799675120 Enrollment ID: O20041221000920 |
News Archive
AIDS Healthcare Foundation (AHF) today applauded decisions by Boehringer Ingelheim (BI) and Gilead Sciences, Inc. to freeze prices on antiretroviral medications purchased by government agencies.
The use of biologics, which are generally made from human and/or animal materials, has significantly changed the management of rheumatoid arthritis over the last decade, becoming the cornerstone treatment for many patients.
Bbiotechnology company NEUROKIN, dedicated to the development of neuroprotective drugs to treat acute neurological diseases, announces today that the European Patent Office (EPO) has granted patent EP 1998778 protecting the use of NK-102, its most advanced drug candidate. This first European award constitutes an important milestone for NEUROKIN. An application for registration is under way in Brazil, Canada, China, USA and Japan.
More than three-quarters of a million low-income adults in Los Angeles County live with hunger or make daily decisions about whether to eat or pay for other essential needs such as shelter or clothing, according to a new UCLA Center for Health Policy Research report.
Less than half of individuals with peripheral artery disease, which is a narrowing of arteries to the limbs, stomach and head, are treated with appropriate medications and lifestyle counseling. These findings highlight the need to improve the quality of care for this high-risk group of individuals.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Seth L Krauss, MD Po Box 200149, Anchorage, AK 99520-0149 Ph: (907) 561-3211 | Seth L Krauss, MD 3841 Piper Street, Suite T100, Anchorage, AK 99508 Ph: (907) 561-3211 |
News Archive
AIDS Healthcare Foundation (AHF) today applauded decisions by Boehringer Ingelheim (BI) and Gilead Sciences, Inc. to freeze prices on antiretroviral medications purchased by government agencies.
The use of biologics, which are generally made from human and/or animal materials, has significantly changed the management of rheumatoid arthritis over the last decade, becoming the cornerstone treatment for many patients.
Bbiotechnology company NEUROKIN, dedicated to the development of neuroprotective drugs to treat acute neurological diseases, announces today that the European Patent Office (EPO) has granted patent EP 1998778 protecting the use of NK-102, its most advanced drug candidate. This first European award constitutes an important milestone for NEUROKIN. An application for registration is under way in Brazil, Canada, China, USA and Japan.
More than three-quarters of a million low-income adults in Los Angeles County live with hunger or make daily decisions about whether to eat or pay for other essential needs such as shelter or clothing, according to a new UCLA Center for Health Policy Research report.
Less than half of individuals with peripheral artery disease, which is a narrowing of arteries to the limbs, stomach and head, are treated with appropriate medications and lifestyle counseling. These findings highlight the need to improve the quality of care for this high-risk group of individuals.
› Verified 9 days ago
Dr. Bijiibaa' K Garrison, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 520-390-8275 | |
Dr. Jeffrey Charles Congdon, MD Surgery Medicare: Medicare Enrolled Practice Location: 2925 Debarr Rd, Anchorage, AK 99508 Phone: 907-257-4869 | |
Kevin Joseph Stange, MD Surgery Medicare: Medicare Enrolled Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-563-2662 | |
Dr. Regina Sutton Chennault, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2751 Debarr Rd, Suite 280a, Anchorage, AK 99508 Phone: 907-222-6888 Fax: 907-222-6884 | |
Mark James Thorndike, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-563-2662 | |
Dr. Priya Patel, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 4001 Laurel St Ste 204, Anchorage, AK 99508 Phone: 907-562-8346 | |
Dr. Madhu Prasad, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2925 Debarr Rd Ste D350, Anchorage, AK 99508 Phone: 907-276-3676 Fax: 907-276-3679 |